Asthma/COPD Differentiation Classification (AC/DC) - Machine learning to aid physicians in diagnosing asthma, COPD and asthma-COPD overlap (ACO)

Alan Kaplan1, Hui Cao2, J. Mark Fitzgerald3, Eric Yang4, Nick Iannotti4, Janwillem W.H. Kocks5, Konstantinos Kostikas6, Paul Mastoridis2, David Price7, Helen K. Reddel8, Ioanna Tsiligianni9, Claus F. Vogelmeier10, Pascal Pfister11 1Family Physician Airways Group of Canada, University of Toronto, Toronto, ON, Canada, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States, 3Department of Medicine, Division of Respiratory Medicine, The University of British Columbia, Vancouver, Canada, 4Novartis Institutes for Biomedical Research, Cambridge, MA, United States, 5General Practitioners Research Institute, Groningen, the Netherlands; Observational and Pragmatic Research Institute, Singapore, 6Respiratory Medicine Department, University of Ioannina Medical School, Ioannina, Greece, 7Observational and Pragmatic Research Institute, Singapore, 8Woolcock Institute of Medical Research, University of Sydney, NSW, Australia, 9Health Planning Unit, Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece, 10Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany, 11Novartis Pharma AG, Basel, Switzerland